Q-omics provides the consensus-scored OLMALINC profile across patient tissues and cancer cell-line models. OLMALINC expression is associated with patient survival in 23 of 34 cancer types, with the highest sampling consensus in LGG. Among the 18 cancer types available for tumor–normal comparison, OLMALINC is differentially expressed in 12, with the highest sampling consensus in THCA. Additionally, OLMALINC RNA expression shows 18,631 significant gene co-expression associations, with the highest sampling consensus in ACC. Together, these results highlight LGG, THCA, and ACC as cancer lineages where OLMALINC shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for OLMALINC — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes OLMALINC survival associations across molecular data types. OLMALINC RNA expression shows survival associations in the most cancer types (23). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible OLMALINC RNA expression–survival associations across cancer types. High OLMALINC expression shows unfavorable associations in KIRC, LIHC and ACC, but favorable associations in LGG, UCS and BLCA. The LGG Kaplan–Meier curve shows clear separation, with the low-expression group declining faster, consistent with the favorable association (log-rank p < 0.001). Together, the overview and detailed table identify LGG as the clearest survival context for OLMALINC RNA expression.
This table summarizes OLMALINC tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 12. The strongest signals are observed in THCA for RNA.
This table ranks reproducible tumor–normal expression differences for OLMALINC. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. OLMALINC shows higher tumor expression in THCA, KICH, KIRC, LIHC, COAD and UCEC. The THCA box plot shows higher OLMALINC RNA expression in tumor versus normal tissue (log2 FC = +0.691, t-test p < 0.001).
This table shows molecular features associated with OLMALINC in patient tissues and cancer cell lines. In patient samples, OLMALINC shows the broadest associations at the RNA and protein expression levels, with ACC recurring as the lineage with the largest associated feature set.
